Conferences & Events

Found 55,555 articles

• Auspherix Presents Pharmacokinetic-Pharmacodynamic (PK/PD) Profile of Its Antibacterial Compounds in Rodents

  10/20/2017

  Auspherix Limited, the anti-infectives company meeting the urgent need for new antibiotics by developing a novel class of antibacterials, today announced that it is presenting proprietary bioanalytical methods to characterise the in vivo pharmacokinetic profile and PK/PD relationship of its compounds, following systemic dosing in rodents.

• Celgene Release: Phase III Efficacy and Safety Data for Oral Ozanimod in Relapsing Multiple Sclerosis to Be Presented at MSParis2017 - 7th Joint ECTRIMS - ACTRIMS Meeting

  10/20/2017

  Celgene announced that new data on the efficacy and safety of ozanimod, a novel, oral, selective, sphingosine 1-phosphate 1 (S1PR1) and 5 (S1PR5) receptor modulator, in relapsing multiple sclerosis (RMS) were accepted for the MSParis2017 - 7th Joint ECTRIMS - ACTRIMS Meeting, which is being held in Paris, October 25-28, 2017.

• Bristol-Myers Squibb to Present New Data Advancing Research Across Serious Liver Diseases At The Liver Meeting 2017

  10/20/2017

  Bristol-Myers Squibb Company today announced that new data across serious liver diseases, including nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), will be presented at The Liver Meeting 2017 in Washington, DC, October 20 - 24, 2017.

• CPhI Worldwide Report States The Current Drugs Pipeline Is Discouraging And Slowing Simple Manufacturing Innovations

  10/20/2017

  CPhI Worldwidee - held in Frankfurt, October 24-26 and organised by UBM - announces the findings of part ii of the 5th edition of the CPhI Annual Report, which focuses on the immediate and long-term trends in pharmaceutical manufacturing and ingredients.

• Galectin Therapeutics to Present Clinical Data at The Liver Meeting 2017 Demonstrating the Ability of Non-Invasive Test to Identify Clinically Significant Portal Hypertension in Patients with Compensated NASH Cirrhosis

  10/20/2017

  Research to be presented demonstrates VCTE liver stiffness measurement is a surrogate for identifying portal hypertension in patients with compensated NASH cirrhosis.

• Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting

  10/20/2017

  The event will be on October 20-24, 2017, at the Washington Convention Center in Washington, D.C.

• Transgene: Third Quarter Marked by Progress in Clinical Development and Research

  10/20/2017

  Transgene, a biotech company that designs and develops viral-based immunotherapies, today announces its business update for the quarter ending September 30, 2017.

• Alnylam and Collaborators to Present APOLLO Phase III Study Results at 1st European ATTR Amyloidosis Meeting for Patients and Doctors

  10/20/2017

  Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the results of the APOLLO Phase 3 study of patisiran in hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy.

• Abiomed's Impella Technology That Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations

  10/20/2017

  The annual scientific symposium of the Cardiovascular Research Foundation will be held October 29 - November 2.

• SuperSonic Imagine to Showcase Next-Generation Aixplorer Ultimate's Solutions for Liver Disease Management at The Liver Meeting 2017

  10/20/2017

  At this DC meeting, attendees will view the system’s 60-second non-invasive evaluation of liver stiffness with real-time ShearWave Elastography.

• Inogen to Announce Third Quarter 2017 Results on Tuesday, November 7, 2017

  10/20/2017

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release its financial results for the third quarter of 2017 after market close on Tuesday, November 7, 2017.

• Medidata Selected for Inaugural Fortune Future 50 List

  10/20/2017

  Medidata, the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it has been selected for the Fortune Future 50 list.

• Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology

  10/20/2017

  Experts to host a variety of presentations at Symposium on Advanced Wound Care Fall Meeting, October 20 to 22, 2017, in Las Vegas, Nevada.

• Exelixis To Release Third Quarter 2017 Financial Results On Wednesday, November 1, 2017

  10/19/2017

  Exelixis announced today that its third quarter 2017 financial results will be released on Wednesday, November 1, 2017.

• Novel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown Bioscience

  10/19/2017

  This webinar will introduce novel tools for investigating human immune response in immunocompetent systems.

• The New Orleans BioInnovation Center Holds the Fifth-Annual Innovation Louisiana Nov. 5 - 10

  10/19/2017

  The New Orleans BioInnovation Center presents the fifth-annual Innovation Louisiana, their flagship event series held each fall, to educate biotech innovators and showcase groundbreaking research being done around the state.

• Science Exchange Honored by Goldman Sachs for Entrepreneurship

  10/19/2017

  Goldman Sachs is recognizing Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange as one of the 100 Most Intriguing Entrepreneurs of 2017 at its Builders & Innovators Summit in Santa Barbara, California.

• PPD Hero Leads Team Supporting Multiple Sclerosis Research

  10/19/2017

  Pharmaceutical Product Development is sponsoring Walk MS: Austin as part of the PPD Heroes initiative to raise awareness about the life-changing impact of clinical research for patients.

• MedDay To Participate In The 7th Joint ECTRIMS - ACTRIMS Meeting In Paris, France

  10/19/2017

  MedDay announces that it will be participating in the 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) -Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting, to be held from 25-28 October 2017 in Paris, France.

• Bio-Rad Release: Genomics Researchers Showcase Their Applications Of Droplet Digital PCR At ASHG 2017 Annual Meeting

  10/19/2017

  The sensitivity and reliability of Droplet Digital PCR will be showcased in over a dozen presentations at the American Society of Human Genetics (ASHG) 2017 Annual Meeting, Orlando, Fla., October 17-21.